I Can't 'Affirm' That You Should Buy AFRM
AFRM could make an oversold bounce of $10 to $20, but let's look at the trend as a Real Money subscriber asks about the stock.
More Big Deals for Health Care Eyed in 2022
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
What Amazon's Charts Are Saying to Investors About the Stock
Is a candle lighting the way higher?
There Are 2 Basic Types of Markets and This One Doesn't Favor Stock Picking
The longer stock picking doesn't work then the greater the opportunities will be when it does work.
What Is the Price of Panic for the Fed?
The Fed has to take some action: No matter how you slice it, 7% CPI is an unacceptable inflation rate. Here's my take on inflation and what's ahead.
I'm on the Lookout for an Intraday Market Reversal
There are signs that a reversal may be brewing and many small-caps and biotechnology names are weak again.
Invest in KB Home? Here's What Traders Could Do
The homebuilder will report it's quarterly results after Wednesday's market close.
Here's Why I'm Fired Up About Energy
The impact of inflation, increased demand as the pandemic fades and the threat of reduced supply all give reason to believe in the sector.
'Hammering' Home a Technical Point: This Pattern Was a Very Good Indicator
The markets have responded to the wash-out of sellers in the prior session as noted by 'hammer' formations.
Brazil's Gerdau Is a Low-Priced Steel Name to Consider
Traders comfortable buying shares in a Brazilian company could probe the long side of GGB at current levels.